Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Antiangiogenic therapies: is VEGF-A inhibition alone enough?
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Antiangiogenic therapies: is VEGF-A inhibition alone enough?
Antiangiogenic therapies: is VEGF-A inhibition alone enough? Expert Rev Anticancer Ther. 2011 Mar; 11(3):485-96.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Disease Progression
Humans
Neoplasms
Vascular Endothelial Growth Factor A
authors with profiles
Michael Scott Gordon, M.D.